These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 25070599)

  • 1. Machines that Go 'Ping': Medical Technology and Health Expenditures in OECD Countries.
    Willemé P; Dumont M
    Health Econ; 2015 Aug; 24(8):1027-41. PubMed ID: 25070599
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Health care spending growth: how different is the United States from the rest of the OECD?
    White C
    Health Aff (Millwood); 2007; 26(1):154-61. PubMed ID: 17211024
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Health spending in OECD countries in 2004: an update.
    Anderson GF; Frogner BK; Reinhardt UE
    Health Aff (Millwood); 2007; 26(5):1481-9. PubMed ID: 17848460
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Spending on medicines in Israel in an international context.
    Sax P
    Isr Med Assoc J; 2005 May; 7(5):286-91. PubMed ID: 15909459
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Income and Technology as Drivers of Australian Healthcare Expenditures.
    You X; Okunade AA
    Health Econ; 2017 Jul; 26(7):853-862. PubMed ID: 27683015
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Assessment of the pharmaceutical expenditure in Hungary].
    Inotai A; Merész G; Kaló Z
    Acta Pharm Hung; 2010; 80(4):162-72. PubMed ID: 21404477
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of newer drugs on health spending: do they really increase the costs?
    Civan A; Köksal B
    Health Econ; 2010 May; 19(5):581-95. PubMed ID: 19404925
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Higher US branded drug prices and spending compared to other countries may stem partly from quick uptake of new drugs.
    Kanavos P; Ferrario A; Vandoros S; Anderson GF
    Health Aff (Millwood); 2013 Apr; 32(4):753-61. PubMed ID: 23569056
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Health care spending and use of information technology in OECD countries.
    Anderson GF; Frogner BK; Johns RA; Reinhardt UE
    Health Aff (Millwood); 2006; 25(3):819-31. PubMed ID: 16684749
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The pervasiveness of pharmaceutical expenditure inertia in the OECD countries.
    Okunade AA; Suraratdecha C
    Soc Sci Med; 2006 Jul; 63(1):225-38. PubMed ID: 16459005
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Trends in Prescription Drug Spending Leading Up to Health Reform.
    Blavin F; Waidmann T; Blumberg LJ; Roth J
    Med Care Res Rev; 2014 Aug; 71(4):416-32. PubMed ID: 24830379
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Robust analysis of the determinants of healthcare expenditure growth: evidence from panel data for low-, middle- and high-income countries.
    Younsi M; Chakroun M; Nafla A
    Int J Health Plann Manage; 2016 Oct; 31(4):580-601. PubMed ID: 27139801
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cross-national comparisons of health systems using OECD data, 1999.
    Reinhardt UE; Hussey PS; Anderson GF
    Health Aff (Millwood); 2002; 21(3):169-81. PubMed ID: 12025981
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ANALYSIS OF TRENDS IN LIFE EXPECTANCIES AND PER CAPITA GROSS DOMESTIC PRODUCT AS WELL AS PHARMACEUTICAL AND NON-PHARMACEUTICAL HEALTHCARE EXPENDITURES.
    Hermanowski T; Bystrov V; Staszewska-Bystrova A; Szafraniec-Buryło SI; Rabczenko D; Kolasa K; Orlewska E
    Acta Pol Pharm; 2015; 72(5):1045-50. PubMed ID: 26665412
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparing the Income Elasticity of Health Spending in Middle-Income and High-Income Countries: The Role of Financial Protection.
    Vargas Bustamante A; V Shimoga S
    Int J Health Policy Manag; 2018 Mar; 7(3):255-263. PubMed ID: 29524954
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Unit root properties of OECD health care expenditure and GDP data.
    MacDonald G; Hopkins S
    Health Econ; 2002 Jun; 11(4):371-6. PubMed ID: 12007167
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Technology as a 'major driver' of health care costs: a cointegration analysis of the Newhouse conjecture.
    Okunad AA; Murthy VN
    J Health Econ; 2002 Jan; 21(1):147-59. PubMed ID: 11852912
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High Spending Growth Rates For Key Diseases In 2000-14 Were Driven By Technology And Demographic Factors.
    Dunn A; Whitmire B; Batch A; Fernando L; Rittmueller L
    Health Aff (Millwood); 2018 Jun; 37(6):915-924. PubMed ID: 29863919
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Health spending in OECD countries: obtaining value per dollar.
    Anderson GF; Frogner BK
    Health Aff (Millwood); 2008; 27(6):1718-27. PubMed ID: 18997231
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An analysis of expenditures on primary care prescription drugs in the United States versus ten comparable countries.
    Morgan SG; Good CB; Leopold C; Kaltenboeck A; Bach PB; Wagner A
    Health Policy; 2018 Sep; 122(9):1012-1017. PubMed ID: 30041827
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.